2B69 Mitchell, Edith P. - Thomas Jefferson University - Thomas Jefferson University
Dr. Mitchell

Edith P. Mitchell, MD, FACP

Contact Dr. Mitchell

925 Chestnut Street
Suite 220A
Philadelphia, PA 19107

(215) 955-8874
(215) 503-9506 fax

Most Recent Peer-reviewed Publications

  1. Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer
  2. Randomized phase II trial of irinotecan/docetaxel or irinotecan/docetaxel plus cetuximab for metastatic pancreatic cancer: An eastern cooperative oncology group study
  3. Determinants of pain severity changes in ambulatory patients with cancer: An analysis from eastern cooperative oncology group trial E2Z02
  4. Determining efficacy of breast cancer therapy by PET imaging of HER2 mRNA
  5. Consistent Surgeon Evaluations of Three-Dimensional Rendering of PET/CT Scans of the Abdomen of a Patient with a Ductal Pancreatic Mass
  6. A randomized, placebo-controlled phase 2 study of ganitumab or conatumumab in combination with FOLFIRI for second-line treatment of mutant KRAS metastatic colorectal cancer
  7. Neoadjuvant chemoradiation for distal rectal cancer: 5-year updated results of a randomized phase 2 study of neoadjuvant combined modality chemoradiation for distal rectal cancer
  8. Targeted Therapy for Metastatic Colorectal Cancer: Role of Aflibercept
  9. Relationship among circulating tumor cells, CEA and overall survival in patients with metastatic colorectal cancer
  10. A Randomized, phase II trial of standard triweekly compared with dose-dense biweekly capecitabine plus oxaliplatin plus bevacizumab as first-line treatment for metastatic colorectal cancer: XELOX-A-DVS (dense versus standard)
  11. Mucinous colloid carcinoma of the colon metastatic to the breast
  12. Radiation therapy oncology group 0247: A randomized phase II study of neoadjuvant capecitabine and irinotecan or capecitabine and oxaliplatin with concurrent radiotherapy for patients with locally advanced rectal cancer
  13. Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
  14. The efficacy and safety of panitumumab administered concomitantly with FOLFIRI or irinotecan in second-line therapy for metastatic colorectal cancer: The secondary analysis from STEPP (skin toxicity evaluation protocol with panitumumab) by KRAS status
  15. Gastric cancer
  16. Do elderly patients experience increased perioperative or postoperative morbidity or mortality when given neoadjuvant chemoradiation before esophagectomy?
  17. The Influence of Prognostic Factors and Adjuvant Chemoradiation on Survival After Pancreaticoduodenectomy for Ampullary Carcinoma
  18. Management of hypersplenism by partial splenic embolization with ethylene vinyl alcohol copolymer
  19. Reply to M. Rother
  20. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers
0